$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Multifunctional nucleic acid monomer 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-019/073
  • C07H-019/06
출원번호 US-0436125 (1995-05-08)
우선권정보 EP-3092033 (1988-10-03); CA-0597309 (1988-10-04); JP-0250726 (1988-10-04)
발명자 / 주소
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA)
출원인 / 주소
  • Chiron Corporation (Emeryville CA 02)
인용정보 피인용 횟수 : 110  인용 특허 : 0

초록

Novel reagents useful in a variety of biochemical and chemical contexts, including nucleic hybridization assays and chemical phosphorylation of hydroxyl-containing compounds. The reagents are particularly useful for introducing cleavable sites and/or abasic sites into oligonucleotide or polynucleoti

대표청구항

A multifunctional nucleic acid monomer having the structure [Figure] wherein R1 is a base,stable acid-sensitive blocking group; R2 is a phosphorous derivative that enables addition of the nucleic acid to the 5′-position of an oligonucleotide chain during chemical synthesis; R3 is selected from the g

이 특허를 인용한 특허 (110)

  1. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  2. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., 5′ modified nucleosides and oligomeric compounds prepared therefrom.
  3. Manoharan, Muthiah; Rajeev, Kallanthottathil G.; Zlatev, Ivan; Swayze, Eric E.; Prakash, Thazha P.; Lima, Walter F., 5′-end derivatives.
  4. Cairns, Belinda; Chen, Ruihuan; Frantz, Gretchen; Hillan, Kenneth J.; Koeppen, Hartmut; Phillips, Heidi S.; Polakis, Paul; Spencer, Susan D.; Smith, Victoria; Williams, P. Mickey; Wu, Thomas D.; Zhang, Zemin, Anti-TAT188 antibodies.
  5. Cairns, Belinda; Chen, Ruihuan; Frantz, Gretchen; Hillan, Kenneth J.; Koeppen, Hartmut; Phillips, Heidi S.; Polakis, Paul; Spencer, Susan D.; Smith, Victoria; Williams, P. Mickey; Wu, Thomas D.; Zhang, Zemin; Sakanaka, Chie; Chuntharapai, Anan; Reed, Chae Janeka, Antibody compositions for the diagnosis and treatment of tumor.
  6. Karelson, Mati; Saarma, Mart; Pilv, Mehis, Antisense agents combining strongly bound base-modified oligonucleotide and artificial nuclease.
  7. Bennett, C. Frank; Cowsert, Lex M.; Siwkowski, Andrew M., Antisense modulation of CD40 expression.
  8. Bornhop, Darryl J.; Mousa, Mina; Kussrow, Amanda, Backscattering interferometric methods.
  9. Fearon, Karen L., Branched immunomodulatory compounds and methods of using the same.
  10. Lisanti, Michael P.; Jasmin, Jean-Francois; Quann, Kevin, Caveolin-1 related methods for treating glioblastoma with temozolomide.
  11. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  12. Bennett, Clarence Frank; Ecker, David J.; Cook, Phillip Dan, Composition and methods for the pulmonary delivery of nucleic acids.
  13. Morris, David W.; Engelhard, Eric K., Compositions and methods for cancer.
  14. Morris, David W.; Engelhard, Eric K., Compositions and methods for cancer.
  15. Akinc, Akin; Nakayama, Tomoko; Manoharan, Muthiah; Stoffel, Markus, Compositions and methods for delivering RNAI using lipoproteins.
  16. Li, Dean; Jones, Christopher; London, Nyall, Compositions and methods for inhibiting vascular permeability.
  17. Akinc, Akin; Nakayama, Tomoko; Konys, David; Stoffel, Markus; Wolfrum, Christian, Compositions and methods for mediating RNAi in vivo.
  18. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  19. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  20. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  21. Mehta, Rahul C.; Hardee, Gregory E.; Cook, Phillip Dan; Ecker, David J.; Tsai, Yali Jennifer; Templin, Michael V., Compositions and methods for topical delivery of oligonucleotides.
  22. Li, Dean; Jones, Christopher; London, Nyall, Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability.
  23. Morris, David W.; Engelhard, Eric K., Compositions and methods in cancer associated with altered expression of KCNJ9.
  24. Morris, David W.; Engelhard, Eric K., Compositions and methods in cancer associated with altered expression of PRLR.
  25. Dobie, Kenneth W.; Dean, Nicholas M.; Bennett, C. Frank, Compositions and their uses directed to HBXIP.
  26. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2'-modified nucleosides for use in gene modulation.
  27. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  28. Capaldi,Daniel C.; Gaus,Hans Joachim Josef; Rentel,Claus Andre Frank; Olsen,Philip Dmitri; Kurata,Christine C.; Song,Quanlai, Compounds and methods for the characterization of oligonucleotides.
  29. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  30. Mirkin, Chad A.; Paller, Amy S.; Giljohann, David A., Delivery of oligonucleotide functionalized nanoparticles.
  31. Gunderson, Kevin; Stuelpnagel, John R.; Chee, Mark S., Detection of nucleic acid reactions on bead arrays.
  32. Gunderson, Kevin; Stuelpnagel, John R.; Chee, Mark S.; Fan, Jian-Bing, Detection of nucleic acid reactions on bead arrays.
  33. Gunderson, Kevin; Stuelpnagel, John R.; Chee, Mark S.; Fan, Jian-Bing, Detection of nucleic acid reactions on bead arrays.
  34. Carvalho,Maria da Gloria; Sampson,Jacquelyn S.; Ades,Edwin W.; Carlone,George; McCaustland,Karen, Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease.
  35. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Diagnosis and treatment of disease.
  36. Kraynack, Bryan A.; Baker, Brenda F.; Bhat, Balkrishen; Swayze, Eric E.; Griffey, Richard H., Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation.
  37. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  38. Leeds Janet M. ; Cummins Lendell L., Fluorescence based nuclease assay.
  39. Swayze, Eric E.; Migawa, Michael T.; Wyrzykiewicz, Tadeusz Krzysztof, Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini.
  40. Ko, Lan; Brooks, Yang Sui, Gene amplification of coactivator CoAA and uses thereof.
  41. Manoharan, Muthiah, Ligand-conjugated oligomeric compounds.
  42. Fu, Glenn K.; Shapero, Michael H.; Wang, Pei-Hua, Locus specific amplification using array probes.
  43. Lisanti, Michael P.; Sotgia, Federica, MCT protein inhibitor-related prognostic and therapeutic methods.
  44. Gilad, Shlomit; Meiri, Esther, Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid.
  45. Gleave, Martin E.; Ischia, Joseph, Method for treatment of castration-resistant prostate cancer.
  46. Bennett Clarence Frank ; Manoharan Muthiah ; Hebert Normand ; Bhat Balkrishen, Methods and compounds for tracking the biodistribution of macromolecule-carrier combinations.
  47. Grasso, Luigi; Liang, Shaohong; Nicolaides, Nicholas C.; Sass, Philip M., Methods of generating high-production of antibodies from hybridomas created by in vitro immunization.
  48. Grasso, Luigi; Liang, Shaohong; Nicolaides, Nicholas C.; Sass, Philip M., Methods of generating high-production of antibodies from hybridomas created by in vitro immunization.
  49. Prakash, Thazha P.; Seth, Punit P.; Manoharan, Muthiah; Swayze, Eric E.; Rajeev, Kallanthottathil G.; Zlatev, Ivan, Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom.
  50. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  51. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  52. Dean Nicholas M. ; McKay Robert, Modulation of c-jun using inhibitors of protein kinase C.
  53. Monia, Brett P.; Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP1 expression.
  54. Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP2 expression.
  55. Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP2 expression.
  56. Bhanot,Sanjay; Dobie,Kenneth W.; Jain,Ravi, Modulation of eIF4E-BP2 expression.
  57. Brown-Driver, Vickie L.; Jain, Ravi, Modulation of transthyretin expression.
  58. Freier, Susan M., Modulation of transthyretin expression.
  59. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Modulation of transthyretin expression.
  60. Bornhop, Darryl J., Multiplexed interferometric detection system and method.
  61. Warthoe,Peter, Nano-mechanic microsensors and methods for detecting target analytes.
  62. Mirkin, Chad A.; Ko, Caroline H.; Stegh, Alexander; Giljohann, David A.; Luciano, Janina; Jensen, Samuel A., Nanoconjugates able to cross the blood-brain barrier.
  63. Wahlestedt, Claes, Natural antisense and non-coding RNA transcripts as drug targets.
  64. Bornhop, Darryl J.; Flowers, Robert A.; Miller, Esther Pesciotta, Nonaqueous backscattering interferometric methods.
  65. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight, Nucleic acid functionalized nanoparticles for therapeutic applications.
  66. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  67. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  68. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nonoparticles for therapeutic applications.
  69. Bentwich, Issac; Avniel, Amir; Aharonov, Ranit; Karov, Yael; Shemer-Avni, Yonat; Levy, Asal, Nucleic acids involved in viral infection.
  70. Andrei P. Guzaev ; Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Nucleosidic and non-nucleosidic folate conjugates.
  71. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen; Guzzaev, Andrei P., Nucleosidic and non-nucleosidic folate conjugates.
  72. Bhat, Balkrishen; Dande, Prasad; Prakash, Thazha P.; Allerson, Charles; Swayze, Eric E.; Griffey, Richard H., Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation.
  73. Swayze, Eric E.; Siwkowski, Andrew M., Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity.
  74. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen, Oligonucleotide analogs having modified dimers.
  75. Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Oligonucleotide analogs having modified dimers.
  76. Albaek, Nanna; Hansen, Henrik Frydenlund; Kammler, Susanne; Ravn, Jacob; Orum, Henrik, Oligonucleotide conjugates.
  77. Moore,Max N.; Andrade,Mark; Carty,Recaldo; Scozzari,Anthony; Krotz,Achim, Oligonucleotide synthesis with alternative solvents.
  78. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen, Oligonucleotide-folate conjugates.
  79. Manoharan, Muthiah, Oligonucleotides conjugated to protein-binding drugs.
  80. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  81. Mirkin, Chad A.; Seferos, Dwight S.; Giljohann, David A., Particles for detecting intracellular targets.
  82. Mirkin, Chad A.; Seferos, Dwight; Giljohann, David A., Particles for detecting intracellular targets.
  83. Manoharan, Muthiah; Maier, Martin A., Peptide-conjugated oligomeric compounds.
  84. Anantharamaiah, Gattadahalli M.; Fogelman, Alan M.; Navab, Mohamad; Rudolf, Martin, Peptides and peptide mimetics to treat pathologies associated with eye disease.
  85. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight S.; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  86. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  87. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  88. Bornhop, Darryl J.; Kammer, Michael, Robust interferometer and methods of using same.
  89. Anantharamaiah, Gattadahalli M.; Garber, David W.; Datta, Geeta; Handattu, Sheila P.; Mishra, Vinod K., Synthetic apolipoprotein E mimicking polypeptides and methods of use.
  90. Anantharamaiah, Gattadahalli M.; White, C. Roger; Gupta, Himanshu, Synthetic apolipoprotein E mimicking polypeptides and methods of use.
  91. Cowsert,Lex M.; Baker,Brenda F.; McNeil,John; Freier,Susan M.; Sasmor,Henri M.; Brooks,Douglas G.; Ohashi,Cara; Wyatt,Jacqueline R.; Borchers,Alexander H.; Vickers,Timothy A., System of components for preparing oligonucleotides.
  92. Donald, Carlton D., Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy.
  93. Donald, Carlton D., Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy.
  94. Donald, Carlton D., Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy.
  95. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  96. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  97. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  98. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  99. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  100. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  101. Morris, David W.; Malandro, Marc S., Therapeutic targets in cancer.
  102. Morris, David W.; Malandro, Marc S., Therapeutic targets in cancer.
  103. Cavanaugh, Shanti A.; Crowley, Mark A.; Spatz, Neil J., Thermal control system for liquid crystal cell.
  104. Faghihi, Mohammad Ali; Coito, Carlos, Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF.
  105. Hanash, Samir M.; Rickman, David; Tyagi, Rachana; Zhu, Xiao-Xiang; Kish, Phillip, Treatments and markers for cancers of the central nervous system.
  106. Chee, Mark S.; Dickinson, Todd A.; Gunderson, Kevin; O'Neil, Don, Use of microfluidic systems in the detection of target analytes using microsphere arrays.
  107. Chee, Mark S.; Dickinson, Todd A.; Gunderson, Kevin; O'Neil, Don, Use of microfluidic systems in the detection of target analytes using microsphere arrays.
  108. Chee, Mark S.; Dickinson, Todd A.; Gunderson, Kevin; O'Neil, Don; Stuelpnagel, John R., Use of microfluidic systems in the detection of target analytes using microsphere arrays.
  109. Bowman, Christopher N.; Rowlen, Kathy; Sikes, Hadley; Hansen, Ryan; Avens, Heather Jean, Use of photopolymerization for amplification and detection of a Molecular Recognition Event.
  110. Rowlen,Kathy L.; Birks,John W.; Bowman,Christopher; Sikes,Hadley; Hansen,Ryan; Kuchta,Robert, Use of photopolymerization for amplification and detection of a molecular recognition event.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로